查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1743803

兽用疫苗市场－全球产业规模、份额、趋势、机会和预测（按疫苗类型、技术、地区和竞争细分，2020-2030 年）

Veterinary Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type, By Technology, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球兽用疫苗市场价值为 84.4 亿美元，预计到 2030 年将以 7.28% 的复合年增长率成长。该市场透过提供用于预防和管理伴侣动物和牲畜疾病的疫苗，在兽医保健中发挥关键作用。这些疫苗对于确保动物健康、维护食品安全和降低人畜共通传染病传播风险至关重要。对合乎道德和永续的动物产品的需求不断增长，再加上疫苗技术的进步和基于平台的新兴疾病解决方案的兴起，正在促进市场扩张。欧洲药品管理局对火鸡疱疹病毒载体平台 Innovax vPTMF 的认证等创新表明了该行业对快速反应和改善疫苗可及性的承诺。随着人们对动物健康的认识不断提高，全球兽用疫苗市场可望强劲成长。

市场概览
预测期 2026-2030
2024年市场规模 84.4亿美元
2030年市场规模 127.6亿美元
2025-2030 年复合年增长率 7.28%
成长最快的领域 减毒活疫苗
最大的市场 北美洲

关键市场驱动因素

动物福利意识不断增强

主要市场挑战

监管障碍和审批流程

主要市场趋势

更加重视预防性医疗保健

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：市场驱动因素、挑战与趋势概述

第五章：顾客之声

第六章：全球兽用疫苗市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依疫苗类型（牲畜疫苗、伴侣动物疫苗）
    • 依技术分类（减毒活疫苗、不活化疫苗、类毒素疫苗、重组疫苗、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第七章：北美兽用疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第八章：欧洲兽用疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第九章：亚太兽用疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第十章：南美兽用疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章：中东和非洲兽用疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 12 章：市场动态

  • 驱动程式
  • 挑战

第十三章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 14 章：全球兽用疫苗市场：SWOT 分析

第 15 章：竞争格局

  • Zoetis Inc.
  • Merck & Co. Inc.
  • Virbac
  • Hester Biosciences Limited
  • Elanco Animal Health
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Phibro Animal Health Corporation
  • HIPRA

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 16220

The Global Veterinary Vaccines Market was valued at USD 8.44 billion in 2024 and is projected to grow at a CAGR of 7.28% through 2030. This market plays a critical role in veterinary healthcare by providing vaccines designed to prevent and manage diseases in both companion animals and livestock. These vaccines are essential for ensuring animal health, maintaining food security, and reducing the risk of zoonotic disease transmission. Growing demand for ethical and sustainable animal products, coupled with advancements in vaccine technology and the rise of platform-based solutions for emerging diseases, are contributing to market expansion. Innovations like the European Medicines Agency's certification of the Innovax vPTMF, a turkey herpesvirus vector platform, demonstrate the industry's commitment to rapid response and improved vaccine accessibility. As awareness around animal health continues to rise, the veterinary vaccines market is poised for strong growth globally.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.44 Billion
Market Size 2030USD 12.76 Billion
CAGR 2025-20307.28%
Fastest Growing SegmentLive Attenuated Vaccine
Largest MarketNorth America

Key Market Drivers

Growing Awareness of Animal Welfare

Increasing public awareness regarding animal welfare is a key factor driving the veterinary vaccines market. Pet owners are more invested in the health of their animals, prioritizing routine vaccinations to extend the life and quality of their pets. Similarly, in livestock farming, the focus on humane treatment and productivity has prompted producers to adopt preventive healthcare strategies, including vaccination. Ethical consumerism is shaping market demand, as buyers prefer products sourced from healthy and well-treated animals. Regulatory frameworks and animal welfare certifications now often include vaccine requirements as part of disease prevention protocols. A notable development is the European Medicines Agency's 2024 certification of the Innovax vPTMF vaccine platform, which enables rapid customization of vaccines to address emerging threats, bolstering preparedness and public health resilience.

Key Market Challenges

Regulatory Hurdles and Approval Processes

The veterinary vaccines market is significantly impacted by the complex and varying regulatory standards across global regions. Navigating country-specific approval processes presents a substantial challenge for manufacturers, often leading to high compliance costs and extended timelines. Regulatory agencies demand rigorous safety and efficacy evaluations, including detailed preclinical and clinical testing. These requirements, while essential for public and animal health, add layers of complexity that slow down time-to-market for new vaccines. Delays in vaccine registration further hinder growth, especially for companies looking to respond swiftly to evolving disease patterns.

Key Market Trends

Increasing Focus on Preventive Healthcare

An emerging trend across the veterinary landscape is the heightened emphasis on preventive care through vaccination. Both pet owners and livestock producers are increasingly aware of the benefits of immunization in minimizing disease outbreaks, reducing treatment costs, and enhancing animal welfare. Preventive healthcare is now viewed as a strategic investment, particularly in the companion animal sector where routine vaccinations are standard. In livestock operations, preventive vaccination supports herd health and productivity, reducing economic losses linked to illness. This trend is reshaping the approach to animal care, prioritizing early intervention and long-term health maintenance.

Key Market Players

  • Zoetis Inc.
  • Merck & Co. Inc.
  • Virbac SA
  • Hester Biosciences Limited
  • Elanco Animal Health
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Phibro Animal Health Corporation
  • HIPRA

Report Scope:

In this report, the Global Veterinary Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Vaccines Market, By Vaccine Type:

  • Livestock Vaccine
  • Companion Animal Vaccine

Veterinary Vaccines Market, By Technology:

  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Other

Veterinary Vaccines Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Vaccines Market.

Available Customizations:

Global Veterinary Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries

4. Overview of Market Drivers, Challenges, Trends

5. Voice of Customer

6. Global Veterinary Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Vaccine Type (Livestock Vaccine, Companion Animal Vaccine)
    • 6.2.2. By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other)
    • 6.2.3. By Region
    • 6.2.4. By Company (2024)
  • 6.3. Market Map

7. North America Veterinary Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Vaccine Type
    • 7.2.2. By Technology
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Veterinary Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Vaccine Type
        • 7.3.1.2.2. By Technology
    • 7.3.2. Canada Veterinary Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Vaccine Type
        • 7.3.2.2.2. By Technology
    • 7.3.3. Mexico Veterinary Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Vaccine Type
        • 7.3.3.2.2. By Technology

8. Europe Veterinary Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Vaccine Type
    • 8.2.2. By Technology
    • 8.2.3. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. Germany Veterinary Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Vaccine Type
        • 8.3.1.2.2. By Technology
    • 8.3.2. United Kingdom Veterinary Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Vaccine Type
        • 8.3.2.2.2. By Technology
    • 8.3.3. Italy Veterinary Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecasty
        • 8.3.3.2.1. By Vaccine Type
        • 8.3.3.2.2. By Technology
    • 8.3.4. France Veterinary Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Vaccine Type
        • 8.3.4.2.2. By Technology
    • 8.3.5. Spain Veterinary Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Vaccine Type
        • 8.3.5.2.2. By Technology

9. Asia-Pacific Veterinary Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Vaccine Type
    • 9.2.2. By Technology
    • 9.2.3. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Veterinary Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Vaccine Type
        • 9.3.1.2.2. By Technology
    • 9.3.2. India Veterinary Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Vaccine Type
        • 9.3.2.2.2. By Technology
    • 9.3.3. Japan Veterinary Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Vaccine Type
        • 9.3.3.2.2. By Technology
    • 9.3.4. South Korea Veterinary Vaccines Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Vaccine Type
        • 9.3.4.2.2. By Technology
    • 9.3.5. Australia Veterinary Vaccines Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Vaccine Type
        • 9.3.5.2.2. By Technology

10. South America Veterinary Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Vaccine Type
    • 10.2.2. By Technology
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Veterinary Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Vaccine Type
        • 10.3.1.2.2. By Technology
    • 10.3.2. Argentina Veterinary Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Vaccine Type
        • 10.3.2.2.2. By Technology
    • 10.3.3. Colombia Veterinary Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Vaccine Type
        • 10.3.3.2.2. By Technology

11. Middle East and Africa Veterinary Vaccines Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Vaccine Type
    • 11.2.2. By Technology
    • 11.2.3. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Veterinary Vaccines Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Vaccine Type
        • 11.3.1.2.2. By Technology
    • 11.3.2. Saudi Arabia Veterinary Vaccines Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Vaccine Type
        • 11.3.2.2.2. By Technology
    • 11.3.3. UAE Veterinary Vaccines Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Vaccine Type
        • 11.3.3.2.2. By Technology

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

  • 13.1. Recent Developments
  • 13.2. Product Launches
  • 13.3. Mergers & Acquisitions

14. Global Veterinary Vaccines Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Zoetis Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Technology Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck & Co. Inc.
  • 15.3. Virbac
  • 15.4. Hester Biosciences Limited
  • 15.5. Elanco Animal Health
  • 15.6. Boehringer Ingelheim International GmbH
  • 15.7. Ceva Sante Animale
  • 15.8. Phibro Animal Health Corporation
  • 15.9. HIPRA

16. Strategic Recommendations

17. About Us & Disclaimer